A truncated reverse transcriptase enhances prime editing by split AAV vectors Z Gao, S Ravendran, NS Mikkelsen, J Haldrup, H Cai, X Ding, ... Molecular Therapy 30 (9), 2942-2951, 2022 | 47 | 2022 |
pegIT-a web-based design tool for prime editing MV Anderson, J Haldrup, EA Thomsen, JH Wolff, JG Mikkelsen Nucleic Acids Research 49 (W1), W505-W509, 2021 | 34 | 2021 |
FRMD6 has tumor suppressor functions in prostate cancer J Haldrup, SH Strand, C Cieza-Borrella, ME Jakobsson, M Riedel, ... Oncogene 40 (4), 763-776, 2021 | 27 | 2021 |
In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit Jun M Riedel, MF Berthelsen, H Cai, J Haldrup, M Borre, SR Paludan, ... Oncogene 40 (13), 2437-2447, 2021 | 24 | 2021 |
piggyPrime: High-efficacy prime editing in human cells using piggyBac-based DNA transposition JH Wolff, J Haldrup, EA Thomsen, S Andersen, JG Mikkelsen Frontiers in Genome Editing 3, 786893, 2021 | 14 | 2021 |
A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer MB Ipsen, EMG Sørensen, EA Thomsen, S Weiss, J Haldrup, A Dalby, ... Oncogene 41 (37), 4271-4281, 2022 | 9 | 2022 |
Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification J Haldrup, S Andersen, ARLV Labial, JH Wolff, FP Frandsen, TW Skov, ... Nucleic Acids Research 51 (18), 10059-10074, 2023 | 5 | 2023 |
Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR J Haldrup, S Andersen, JÂG Mikkelsen Cas ribonucleoprotein complexes supporting base editing, prime editing and …, 2023 | 5 | 2023 |
Simple autofluorescence-restrictive sorting of eGFP+ RPE cells allows reliable assessment of targeted retinal gene therapy S Alsing, AB Lindholm, J Haldrup, EG Jensen, JG Mikkelsen, L Aagaard, ... Frontiers in Drug Delivery 2, 898568, 2022 | 4 | 2022 |
Investigation of enzalutamide, docetaxel, and cabazitaxel resistance in the castration resistant prostate cancer cell line C4 using genome-wide CRISPR/Cas9 screening J Haldrup, S Weiss, L Schmidt, KD Sørensen Scientific Reports 13 (1), 9043, 2023 | 3 | 2023 |